Xuyang Peng
-
- Chemotherapy-induced cardiotoxicity and mitigation 4
-
- HER2/EGFR in Cancer Research 3
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
-
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 3
- Angiogenesis and VEGF in Cancer 3
- Metabolism, Diabetes, and Cancer 3
- Co-authors
- Douglas B. SawyerLaura PentassugliaBilly ChenChee Chew LimRadwan SafaHolly SmithAjit BhartiSteven C. Borkan
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xuyang Peng
26 papers receiving 825 citations
Peers
Comparison fields: 5 of 89
- Cardiology and Cardiovascular Medicine 441
- Oncology 217
- Cancer Research 82
- Endocrinology, Diabetes and Metabolism 89
- Molecular Biology 350
Countries citing papers authored by Xuyang Peng
This map shows the geographic impact of Xuyang Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuyang Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuyang Peng more than expected).
Fields of papers citing papers by Xuyang Peng
This network shows the impact of papers produced by Xuyang Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuyang Peng. The network helps show where Xuyang Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuyang Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2022 | 2 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 14 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 9 | |
| 8 | 2020 | 4 | |
| 9 | 2020 | 3 | |
| 10 | 2019 | 1 | |
| 11 | 2019 | 6 | |
| 12 | 2012 | 15 | |
| 13 | 2012 | 52 | |
| 14 | 2012 | 28 | |
| 15 | 2011 | 41 | |
| 16 | 2011 | 19 | |
| 17 | 2010 | 200 | |
| 18 | 2008 | 16 | |
| 19 | 2007 | 122 | |
| 20 | 2005 | 59 |
About Xuyang Peng
Xuyang Peng is a scholar working on Cancer Research, Immunology and Allergy and Cardiology and Cardiovascular Medicine, having authored 27 papers that have together received 838 indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), MicroRNA in disease regulation (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Cancer-related molecular mechanisms research (4 papers), Epigenetics and DNA Methylation (3 papers), HER2/EGFR in Cancer Research (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (441 citations), Oncology (217 citations) and Cancer Research (82 citations). Xuyang Peng has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Douglas B. Sawyer, Laura Pentassuglia, Billy Chen, Chee Chew Lim, Radwan Safa, Holly Smith, Ajit Bharti, Steven C. Borkan, Nobuyuki Takakura and Kari Alitalo. Their work appears in journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.